Failure to detect ventricular fibrillation in a patient with an implantable cardioverter-defibrillator

被引：0
|
作者：
Antolinos-Perez, Maria J. [1 ]
Garcia-Alberola, Arcadio [1 ]
Valdes-Chavarri, Mariano [1 ]
机构：
[1] Hosp Univ Virgen Arrixaca, Unidad Arritmias, Serv Cardiol, Murcia, Spain
来源：
REVISTA ESPANOLA DE CARDIOLOGIA | 2006年 / 59卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：517 / 518
页数：2
相关论文
共 50 条
  • [31] Implantable cardioverter-defibrillator in a patient with left ventricular non-compaction cardiomyopathy
    Gorczyca-Michta, Iwona
    Spalek, Michal
    Wozakowska-Kaplon, Beata
    KARDIOLOGIA POLSKA, 2017, 75 (11) : 1211 - 1211
  • [32] RAPID CORRECTION OF HYPOKALEMIA IN A PATIENT WITH AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR AND RECURRENT VENTRICULAR TACHYCARDIA
    Philips, David A.
    Bauch, Terry D.
    JOURNAL OF EMERGENCY MEDICINE, 2010, 38 (03): : 308 - 316
  • [33] Ventricular Oversensing after Replacement of an Implantable Cardioverter-Defibrillator
    Arias, Miguel A.
    Puchol, Alberto
    Castellanos, Eduardo
    Pachon, Marta
    Rodriguez-Padial, Luis
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2009, 32 (07): : 925 - 927
  • [34] Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing
    Welte, Nicolas
    Strik, Marc
    Eschalier, Romain
    Mondoly, Pierre
    Defaye, Pascal
    Frontera, Antonio
    Ritter, Philippe
    Haissaguerre, Michel
    Ploux, Sylvain
    Koneru, Jayanthi
    Ellenbogen, Kenneth A.
    Bordachar, Pierre
    HEART RHYTHM, 2017, 14 (07) : 1008 - 1015
  • [35] Risk of Failure of Transvenous Implantable Cardioverter-Defibrillator Leads
    Borleffs, C. Jan Willem
    van Erven, Lieselot
    van Bommel, Rutger J.
    van der Velde, Enno T.
    van der Wall, Ernst E.
    Bax, Jeroen J.
    Rosendaal, Frits R.
    Schalij, Martin J.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (04): : 411 - 416
  • [36] Implantable cardioverter-defibrillator treatment and resynchronisation in heart failure
    Linde, C
    HEART, 2004, 90 (02) : 231 - 234
  • [37] Celivarone in patients with an implantable cardioverter-defibrillator: Adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventions
    Gojkovic, Olivera
    Aliot, Etienne M.
    Capucci, Alessandro
    Connolly, Stuart J.
    Crijns, Harry
    Hohnloser, Stefan H.
    Kulakowski, Piotr
    Roy, Denis
    Radzik, David
    Singh, Bramah N.
    Kowey, Peter R.
    HEART RHYTHM, 2012, 9 (02) : 217 - U2
  • [38] Lead failure in an entirely subcutaneous implantable cardioverter-defibrillator
    Kolb, Christof
    Weigand, Severin
    Schaarschmidt, Claudia
    Lennerz, Carsten
    EUROPACE, 2020, 22 (02): : 183 - 183
  • [39] Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
    Bardy, GH
    Lee, KL
    Mark, DB
    Poole, JE
    Packer, DL
    Boineau, R
    Domanski, M
    Troutman, C
    Anderson, J
    Johnson, G
    McNulty, SE
    Clapp-Channing, N
    Davidson-Ray, LD
    Fraulo, ES
    Fishbein, DP
    Luceri, RM
    Ip, JH
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03): : 225 - 237
  • [40] Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator
    Gardiwal, Ajmal
    Yu, Hong
    Oswald, Hanno
    Luesebrink, Ulrich
    Ludwig, Andreas
    Pichlmaier, Andreas Maximilian
    Drexler, Helmut
    Klein, Gunnar
    EUROPACE, 2008, 10 (03): : 356 - 361
12345